Cardiff Lexington Corporation (CDIX)

Market Cap	21.40M +9,811.9%
Revenue (ttm)	10.84M +22.3%
Net Income	-9.21M
EPS	-0.99
Shares Out	15.28M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	1.550
Previous Close	1.718
Day's Range	1.400 - 1.550
52-Week Range	0.934 - 18.690
Beta	1.68
Analysts	n/a
Price Target	n/a
Earnings Date	May 19, 2026

About Cardiff Lexington

Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstructi...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Alex Cunningham
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: CDIX

Financial Performance

In 2025, Cardiff Lexington's revenue was $11.54 million, an increase of 39.48% compared to the previous year's $8.27 million. Losses were -$6.54 million, 53.4% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 15, 2026

Data Sources Report a data error